Navigation Links
Exiqon Announces Positive Clinical Data From EORTC Clinical Trial Showing Oncotech EDR Assay Predicts Resistance to Platinum-Based Therapy in Ovarian Cancer
Date:10/27/2008

VEDBAEK, Denmark, October 27 /PRNewswire-FirstCall/ -- The European Organization for Research and Treatment of Cancer (EORTC) has undertaken a multi-institutional prospective randomized clinical trial on 719 late stage epithelial ovarian cancer patients (named 55971). Results were announced today at the 2008 International Gynecologic Cancer Society (IGCS) biennial meeting in Bangkok, Thailand. In this study, Oncotech EDR Assays were performed on biopsies obtained from 246 patients. Results clearly demonstrate that resistance to carboplatin, as identified by the Oncotech EDR Assay, was a significant independent predictor for response to first-line treatment in advanced ovarian cancer patients.

The clinical trial results demonstrate that the use of the Oncotech EDR Assay predictive test can predict resistance to platinum-based chemotherapy before therapy is initiated. These results are important to ovarian cancer treating physicians since ovarian cancer is known to show resistance to platinum-based agents. Currently, the standard first-line treatment regimen for late stage ovarian cancer contains platinum-based chemotherapy.

Dr. Ignace Vergote, President of the IGCS and Coordinator of the trial, commented, "The results of this study provide additional evidence that resistance to a platinum-based therapy, as predicted by the Oncotech EDR Assay, is a significant negative predictor of response to first line platinum-based chemotherapy. This information is important since it allows the treating physician to consider alternative regimens earlier in the treatment plan which might benefit the patient."

Dr. Cynthia French, Exiqon Diagnostics Chief Scientific Officer, stated, "The Oncotech EDR Assay has once again been proven through clinical studies to be a valuable tool in individualizing medicine for cancer patients. We are very pleased to share the positive results of this trial conducted by the prestigious EORTC and are looking forward to conti
'/>"/>

SOURCE Exiqon A/S
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Exiqon: Major Shareholder Announcement
2. Exiqon Appoints Cynthia French as Chief Scientific Officer and Erik Holmlin as Chief Commercial Officer
3. Exiqon Receives the 2008 Frost & Sullivan Growth Strategy Leadership Award
4. Exiqon A/S: Interim Report for the Period 1 January - 30 June 2008 (Unaudited)
5. Report Regarding the Managements and Closely Related Parties Transactions With Securities in Exiqon A/S
6. Exiqon A/S Today Announces a Grant of License to Roche Diagnostics
7. Exiqon A/S Announces U.S. Subsidiary Name Change From Oncotech, Inc. to Exiqon Diagnostics, Inc.
8. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
9. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
10. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
11. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/19/2014)... , Aug. 19, 2014   Synthetic Biologics, ... developing novel anti-infective biologic and drug programs targeting ... announced today that its novel C. difficile ... 54 th Interscience Conference on Antimicrobial Agents ... Washington D.C. Synthetic Biologics, ...
(Date:8/18/2014)... (PRWEB) August 19, 2014 2014 ... Industryā€¯ is a professional and in-depth research report ... basic Linalool information, including its definition, classification, ... industry overview. This research covers the international market ... global industry analysis covering macroeconomic environment & economic ...
(Date:8/18/2014)... FREDERICK, Md. , Aug. 18, 2014 ... the maker of advanced consumer medical devices ... Kotak was interviewed by CEOLIVE.TV as ... The entire interview is available at ... interview Dr. Kotak explains to investors the ...
(Date:8/18/2014)... August 18, 2014 Global HIV Infection ... report announced by Reportstack. The rate of HIV infection and ... a declining note at a positive rate across the globe. ... 2.3 million in 2005 to 1.5 in 2013, with the ... for such drastic changes in the infection rates has been ...
Breaking Biology Technology:Synthetic Biologics Announces Late-Breaking Poster Presentation for C. difficile Program at 54th ICAAC 2Synthetic Biologics Announces Late-Breaking Poster Presentation for C. difficile Program at 54th ICAAC 3Synthetic Biologics Announces Late-Breaking Poster Presentation for C. difficile Program at 54th ICAAC 4Linalool Industry & Diphenylamine Market (Global, China) 2014 Analysis Now Available at DeepResearchReports.com 2Linalool Industry & Diphenylamine Market (Global, China) 2014 Analysis Now Available at DeepResearchReports.com 3Linalool Industry & Diphenylamine Market (Global, China) 2014 Analysis Now Available at DeepResearchReports.com 4BioElectronics EVP Dr. Deepak Kotak Interviewed on CEO Live 2BioElectronics EVP Dr. Deepak Kotak Interviewed on CEO Live 3Global HIV Infection Drug Market Overview 2Global HIV Infection Drug Market Overview 3Global HIV Infection Drug Market Overview 4
... Will Help Drive Company,s Commercialization of,Eligen(R) Technology, ... (Nasdaq: EMIS ) has announced that Nicholas ... of Strategy and Development. In this,capacity, Mr. Hart ... aspects of the company,s Eligen(R) technology, including,Eligen(R) B12., ...
... & Co., Inc. Biomarker,Imaging Program -, - ... Broadens Applications in Key Areas of Disease Research ... VisEn Medical, Inc., a leader,in fluorescence in ... commercial launch of its IntegriSenseTM fluorescence in vivo,imaging ...
... Detect Toxicity -, HOPKINTON, Mass., Aug. 19 ... that it has received a $1.1,million task order under ... This task order was issued,pursuant to a contract that ... the ToxCast program. The contract provides for up to ...
Cached Biology Technology:Nicholas J. Hart Joins Emisphere as Vice President, Strategy and Development 2Nicholas J. Hart Joins Emisphere as Vice President, Strategy and Development 3VisEn Announces Commercial Launch of IntegriSenseTM Fluorescence Molecular Imaging Agent 2Caliper Life Sciences Receives $1.1 Million Task Order from the EPA's ToxCast(TM) Screening Program 2Caliper Life Sciences Receives $1.1 Million Task Order from the EPA's ToxCast(TM) Screening Program 3Caliper Life Sciences Receives $1.1 Million Task Order from the EPA's ToxCast(TM) Screening Program 4
(Date:8/19/2014)... Aug. 19, 2014 To improve students, chances ... grades, the University of Houston (UH) implemented a ... students at risk for failure. , Through ... Board (THECB), the Department of Biology and Biochemistry ... students taking "General Biology" for non-majors and "Introductory ...
(Date:8/19/2014)... Eos: Long-Term Ecological Research and Network-Level Science, , Imagine ... wide range of ecosystems was responding to global changes ... powerful if it coupled multiple decades of information about ... and models from dozens of different ecosystem types. ... Long-Term Ecological Research (LTER) Network, which will soon celebrate ...
(Date:8/19/2014)... at retail seafood counters in 10 different states ... consumers to unexpectedly high levels of mercury, a ... a fish of the same species, but from ... offense, according to new research by University of ... seafood is essential to allow consumers to choose ...
Breaking Biology News(10 mins):University of Houson program earns kudos for improving grades, retaining students 2University of Houson program earns kudos for improving grades, retaining students 3This week from AGU: Long-term ecological research, predicting cholera outbreaks 2Seafood substitutions can expose consumers to unexpectedly high mercury 2Seafood substitutions can expose consumers to unexpectedly high mercury 3
... of storm surge and sea-level rise have become ... weeks following Hurricane Sandy,s catastrophic landfall along the ... Brubaker of the Virginia Institute of Marine Science ... sea-level variabilitythe "intra-seasonal" changes that occupy the middle ...
... a glacier,s past, potentially allowing them to more accurately assess how ... been published today, 27 November, in IOP Publishing,s journal Environmental ... can be extended way past the instrumental record. Much ... is, measuring the width of rings on the stem of a ...
... 26, 2012 Webcast AdvisoryWhat:Announcement of a state-of-the-art pediatric ... team racing to unlock genomic codes and develop ... biomedical breakthroughs that will give new hope to ... Hospital, in collaboration with Translational Genomics Research Institute ...
Cached Biology News:Researcher studies 'middle ground' of sea-level change 2Researcher studies 'middle ground' of sea-level change 3Researcher studies 'middle ground' of sea-level change 4Researcher studies 'middle ground' of sea-level change 5Shrubs lend an insight into a glacier's past 2
...
... Clone/PAD: ZMD.358. Immunogen: Synthetic ... region of human mouse and ... with human and mouse LRP5 ... (positive controls: mouse LRP5-pSEC-tag-transfected 293T ...
...
Replacement Parts for Electrophoresis Apparatus...
Biology Products: